findmyKOL

Tuhina Neogi, MD

Enriched profile

Chief of Rheumatology, Boston Medical Center; Professor of Medicine & Section Chief of Rheumatology, Boston University Chobanian & Avedisian School of Medicine; Alan S. Cohen, MD Professor of Rheumatology · Boston University Chobanian & Avedisian School of Medicine

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyRheumatologyFocusOsteoarthritis
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2007–2026

Tuhina Neogi is Chief of Rheumatology, Boston Medical Center; Professor of Medicine & Section Chief of Rheumatology, Boston University Chobanian & Avedisian School of Medicine; Alan S. Cohen, MD Professor of Rheumatology at Boston University Chobanian & Avedisian School of Medicine. OpenAlex indexes 641 publications with 47,556 citations (h-index 84); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Tuhina Neogi, MD, is Chief of Rheumatology, Boston Medical Center at Boston University Chobanian & Avedisian School of Medicine. The public record shows 641 publications with 47,556 citations (h-index 84), centered on Osteoarthritis. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 17 companies, 10 NIH-funded awards (2007–2026).

  • Most recent indexed publication: 2026 · Arthritis & rheumatology (Hoboken, N.J.)
  • Top research focus: Osteoarthritis
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Osteoarthritis1 trialChondrocalcinosis1 trial

Research focus

OpenAlex concept fingerprint
Osteoarthritis

Drugs & molecules

across trials, industry payments and publications
CorticotropinClinical trialsIndustry payments8PublicationsKrystexxageneric · PegloticaseClinical trialsIndustry payments6PublicationsGamifantgeneric · EmapalumabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trialsIndustry payments9Exeltis, USA Inc.Clinical trialsIndustry payments8Horizon Therapeutics plcClinical trialsIndustry payments6

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
641publications

Distinct works indexed by OpenAlex, matched via ORCID; 105 in PubMed.

47,556citations

Total citations across indexed works.

84h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
10NIH grants · 2007–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    42.5%
    TNF inhibitor24.8%
    Humira Pen100%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor17.8%
    Methotrexate100%
    Part D<11 patients
  • Musculoskeletal

    30.8%
    Xanthine oxidase inhibitor12.6%
    Allopurinol100%
    Part D<11 patients
    Alkaloid11.7%
    Colchicine100%
    Part D<11 patients
  • Nervous system

    12.6%
    Nonsteroidal Anti-inflammatory Drug6.5%
    Meloxicam100%
    Part D<11 patients
    Gabapentinoids6.1%
    Pregabalin100%
    Part D<11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

10 NIH research awards on record, funded 20072026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/tuhina-neogi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • X / Twitter

    x.com/Tuhina_Neogi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • LinkedIn

    linkedin.com/in/tuhina-neogi-119a481

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • LinkedIn

    linkedin.com/posts/american-college-of-rheumatology_acr25-activity-7384591213233938432-raRH

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/posts/boston-medical-center_were-proud-to-share-that-bmcs-chief-of-activity-7388952860291510272-l6eX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • Other

    profiles.bu.edu/Tuhina.Neogi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.bu.edu
13 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • PhD

    Epidemiology, Boston University School of Public Health

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bmc.org
  • MD

    University of Toronto Faculty of Medicine

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bmc.org
  • BS

    McMaster University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu
  • Board Certified

    Rheumatology, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bmc.org

Editorial & leadership roles

journal and society appointments
  • Past Chair

    FDA Arthritis Advisory Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu
  • Board Member

    Osteoarthritis Research Society International (OARSI)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu
  • Board Member

    Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu
3 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Professor of Epidemiology

    Boston University School of Public Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu
  • Investigator

    Framingham Heart Study

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →framinghamheartstudy.org
  • Member

    Arthritis & Autoimmune Diseases Research Center, Boston University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
  • The Curbsiders podcast

    episode #177: "Osteoarthritis Master Class with Tuhina Neogi MD, PhD"

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thecurbsiders.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.